Invus Financial Advisors, LLC - Q4 2022 holdings

$188 Million is the total value of Invus Financial Advisors, LLC's 9 reported holdings in Q4 2022. The portfolio turnover from Q3 2022 to Q4 2022 was 12.5% .

 Value Shares↓ Weighting
CPNG SellCoupang Inccl a$40,696,259
-19.9%
2,766,571
-9.2%
21.65%
-22.3%
RCUS  Arcus Biosciences Inc$33,337,752
-20.9%
1,612,0770.0%17.74%
-23.4%
OYST  Oyster Point Pharma Inc$30,925,106
+98.8%
2,768,5860.0%16.46%
+92.7%
NVCR  Novocure Ltd$25,737,341
-3.5%
350,8840.0%13.70%
-6.4%
TBLA  Taboola.com Ltd$24,084,645
+70.2%
7,819,6900.0%12.82%
+65.0%
 Nu Hldgs Ltd$22,722,607
-7.5%
5,582,9500.0%12.09%
-10.3%
ORIC  Oric Pharmaceuticals Inc$5,934,617
+84.1%
1,007,5750.0%3.16%
+78.4%
 IONQ Inc$3,450,000
-32.0%
1,000,0000.0%1.84%
-34.0%
NewIHS Holding Limited$1,048,932170,558
+100.0%
0.56%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2023-02-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
Arcus Biosciences Inc16Q3 202324.7%
Novocure Ltd16Q3 202325.4%
Oric Pharmaceuticals Inc14Q3 202314.3%
Oyster Point Pharma Inc13Q4 202244.5%
Coupang Inc11Q3 202351.6%
Taboola.com Ltd10Q3 202323.7%
Unity Biotechnology Inc9Q4 20218.0%
Yext Inc8Q3 202130.3%
IONQ Inc8Q3 20237.2%
Nu Hldgs Ltd6Q3 202325.4%

View Invus Financial Advisors, LLC's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-02-14
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
13F-HR2023-02-14
13F-HR2022-11-14
13F-HR2022-08-15
13F-HR2022-05-16
13F-HR2022-02-14
13F-HR2021-11-15

View Invus Financial Advisors, LLC's complete filings history.

Compare quarters

Export Invus Financial Advisors, LLC's holdings